Vimarsana
Biggest News Aggregation in the World

Page 32 - Reason Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Reason Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Reason Research Today - Breaking & Trending Today

Unicycive Announces Second Quarter 2023 Financial Results and Provides Business Update - Vimarsana News

Unicycive Announces Second Quarter 2023 Financial Results and Provides Business Update

14.08.2023 - Recent Data Publications Highlight the Benefits of Oxylanthanum Carbonate (OLC) to Improve Medication Adherence and Quality of Life for Patients with Chronic Kidney Disease Feedback from FDA Expected in Fall 2023 for OLC Program UNI-494 ...

Unicycive Therapeutics Announces Publication of Positive - Vimarsana News

Unicycive Therapeutics Announces Publication of Positive

Newly Assigned USAN Name, Oxylanthanum Carbonate, replaces Lanthanum Dioxycarbonate...

Unicycive Therapeutics Provides Regulatory Update on Lanthanum Dioxycarbonate Program - Vimarsana News

Unicycive Therapeutics Provides Regulatory Update on Lanthanum Dioxycarbonate Program

LOS ALTOS, Calif., June 29, 2023 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), t...

Unicycive Therapeutics Provides Regulatory Update on - Vimarsana News

Unicycive Therapeutics Provides Regulatory Update on

LOS ALTOS, Calif., June 29, 2023 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing...

Technical recession equals buy stocks - Vimarsana News

Technical recession equals buy stocks

US GDP had a nasty surprise for everybody overnight, unexpectedly falling by 0.90%, when market expectations were for a modest 0.50% gain. That marked